Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients

Limited knowledge exists as to what impact preoperative biologic therapy has on postoperative complications in pediatric patients undergoing abdominal surgery for Crohn's disease (CD). Therefore, we sought to determine the 30-day postoperative infectious complication rate among pediatric CD patients who received biologic therapy within 12  weeks of an abdominal operation.

Source: Journal of Pediatric Surgery - February 14, 2019 Category: Surgery Authors: Amy L. Lightner, Nicholas P. McKenna, Ahmad Alsughayer, Edward V. Loftus, Laura E. Raffals, William A. Faubion, Christopher Moir Source Type: research